8279 On Other Exchanges
Symbol
Exchange
Taiwan

syngen biotech co ltd (8279) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SYNGEN BIOTECH CO LTD (8279)
\

Related News

No related news articles were found.

syngen biotech co ltd (8279) Related Businessweek News

No Related Businessweek News Found

syngen biotech co ltd (8279) Details

Syngen Biotech Co., Ltd. operates as a biotech company in Taiwan. The company manufactures and sells active pharmaceutical ingredients, including Mupirocin, an antibiotic against gram-positive bacteria that is used for the topical treatment of superficial infections; and nutraceutical ingredients comprising probiotics, medicinal fungi, and entomogenous fungi. It also offers biology fermentation products, biology agriculture and aquaculture products, and functional food products. The company was founded in 1999 and is based in Tainan City, Taiwan.

Founded in 1999

syngen biotech co ltd (8279) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

syngen biotech co ltd
Syngen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019

Syngen Biotech Co., Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was TWD 264.395 million compared to TWD 192.824 million a year ago. Operating income was TWD 41.233 million compared to TWD 14.575 million a year ago. Net income was TWD 33.662 million compared to TWD 14.883 million a year ago. Basic earnings per share was TWD 1.46 compared to TWD 0.64 a year ago.

Syngen Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018

Syngen Biotech Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 1,080.453 million compared to TWD 955.647 million a year ago. Operating income was TWD 166.149 million compared to TWD 172.518 million a year ago. Net income was TWD 133.990 million compared to TWD 148.618 million a year ago. Basic earnings per share was TWD 5.8 compared to TWD 6.43 a year ago. Diluted earnings per share was TWD 5.79 compared to TWD 6.43 a year ago.

Syngen Biotech Co., Ltd., Annual General Meeting, Jun 12, 2019

Syngen Biotech Co., Ltd., Annual General Meeting, Jun 12, 2019.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

8279 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8279.
View Industry Companies
 

Industry Analysis

8279

Industry Average

Valuation 8279 Industry Range
Price/Earnings 18.9x
Price/Sales 2.5x
Price/Book 3.2x
Price/Cash Flow 18.8x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SYNGEN BIOTECH CO LTD, please visit www.syngen.com.tw. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.